Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soligenix, Inc. - Common Stock (NQ:SNGX)

2.780 -0.160 (-5.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 284,204
Open 2.820
Bid (Size) 2.650 (2)
Ask (Size) 2.800 (3)
Prev. Close 2.940
Today's Range 2.680 - 2.868
52wk Range 1.090 - 5.400
Shares Outstanding 3,504,950
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
Via Investor Brand Network
Study Finds That Low BSA Psoriasis Could Have a High Disease Burden
Via Investor Brand Network

Performance

YTD
-5.4%
-5.4%
1 Month
+109.0%
+109.0%
3 Month
+49.5%
+49.5%
6 Month
+16.3%
+16.3%
1 Year
-16.8%
-16.8%

More News

Read More
BioMedNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Q2 2025 Results Highlight Progress in Late-Stage Rare Disease Pipeline
Via Investor Brand Network
InvestorNewsBreaks – Alliance Global Partners Maintains Buy Rating, Increases Price Target as Soligenix Inc. (NASDAQ: SNGX) Advances Proprietary Clinical Programs
Via Investor Brand Network
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Featured in NNW Editorial on Rare Disease Innovation
Via Investor Brand Network
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
From Soligenix, Inc.
Via GlobeNewswire
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
Via Investor Brand Network
Topics Government
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
Via FinancialNewsMedia
Topics Government
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Spotlighted in Editorial on Rare Disease Therapeutics
Via Investor Brand Network
Study Finds That Inflammation Markers in Diabetics Influence Depression Treatment Outcomes
Via Investor Brand Network
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
From Soligenix, Inc.
Via GlobeNewswire
Unusual volume stocks in Monday's session
Via Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via Investor Brand Network
Topics Government
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via FinancialNewsMedia
Topics Government
Loop Industries (Nasdaq: LOOP) Unveils Game-Changing Twist™ Polyester Made Entirely from Textile Waste – More Stocks Inside
Via AB Newswire
Topics Economy Emissions Energy
What's going on in today's session
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Crude Oil Falls 1%; Meta Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Thursday's session: gap up and gap down stocks
Via Chartmill
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings
Via Benzinga
InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Achieves Biological Efficacy in Phase 2a SGX945 Study for Behçet’s Disease
Via Investor Brand Network
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Soligenix, Inc. - Common Stock publicly traded?
Yes, Soligenix, Inc. - Common Stock is publicly traded.
What exchange does Soligenix, Inc. - Common Stock trade on?
Soligenix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Soligenix, Inc. - Common Stock?
The ticker symbol for Soligenix, Inc. - Common Stock is SNGX on the Nasdaq Stock Market
What is the current price of Soligenix, Inc. - Common Stock?
The current price of Soligenix, Inc. - Common Stock is 2.780
When was Soligenix, Inc. - Common Stock last traded?
The last trade of Soligenix, Inc. - Common Stock was at 08/15/25 04:00 PM ET
What is the market capitalization of Soligenix, Inc. - Common Stock?
The market capitalization of Soligenix, Inc. - Common Stock is 9.74M
How many shares of Soligenix, Inc. - Common Stock are outstanding?
Soligenix, Inc. - Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.